(Globe Newswire) Charlottetown, P.E.I and Skopje, North Macedonia – Advanced Extraction Systems Inc and Pharmarolly Holdings B.V. are excited to announce that Pharmarolly has successfully passed the stringent euGMP audit and obtained full euGMP certification for their pharmaceutical facility. This achievement underscores both companies’ unwavering dedication to meeting the highest European standards for pharmaceutical manufacturing.
This certification reflects Pharmarolly’s adherence to the stringent regulations established by the European Medicines Agency (EMA). It ensures that their facility and processes are maintained at the highest levels of quality and safety, reinforcing Pharmarolly’s position as an industry leader.
“Achieving euGMP certification is a testament to our team’s hard work and dedication to quality,” said Steve Malloy, CEO of Pharmarolly. “We have set ourselves a high bar, and meeting the rigorous requirements of the euGMP audit demonstrates our steadfast commitment to delivering pharmaceutical products that meet the highest standards. This milestone is a significant step in our journey, and we’re excited about the opportunities it brings.”
Peter Toombs, CEO of AESI, added, “We are thrilled to see Pharmarolly achieve this important milestone. Their dedication to excellence and strict adherence to euGMP guidelines have been evident throughout this process. AESI has long been a leader in the natural products space, including the cannabis industry, and we continue to see significant success through our partnerships and projects. We are honored to have been part of Pharmarolly’s journey and look forward to continuing our partnership as they expand their reach in the pharmaceutical industry.”
Advertisement
This achievement not only validates the quality of Pharmarolly’s operations but also highlights their strong partnership with AESI, whose technology and expertise have supported the company’s efforts to achieve and maintain the highest standards in pharmaceutical manufacturing.
